UT HB0389

Transfers all medical cannabis program oversight duties from the Department of Health and Human Services to the Department of Agriculture and Food (UDAF), including control of the Qualified Patient Enterprise Fund

Renames the Cannabis Production Establishment and Pharmacy Licensing Advisory Board to the Specialized Product Authority Licensing Board and reconstitutes it as three hired directors serving at the commissioner's pleasure, rather than appointed volunteer members

Requires industrial hemp retailers to verify purchasers of THC-containing cannabinoid products are at least 21 years old, while repealing the video surveillance requirement for these retailers

Allows medical cannabis processors to produce and pharmacies to sell "low THC products" containing less than 0.3% THC without obtaining a separate hemp processor license

Creates authority for UDAF to impose a uniform fee on medical cannabis pharmacy transactions for enforcement purposes, and expands the Qualified Production Enterprise Fund's allowable uses to include hemp and kratom enforcement